BIOQBIOQUAL, Inc.

About BIOQUAL, Inc. (BIOQ)

BIOQUAL, Inc. (BIOQ) is a N/A company headquartered in Rockville, MD, United States whose shares trade over-the-counter on the Pink tier.

BIOQUAL, Inc. is committed to providing quality research, model development, pre-clinical, testing/assay, and consulting services to commercial clients and Government laboratories.

Products and services

The Company supports the National Institutes of Health and commercial clients by providing research services in the following in-vitro and in-vivo research areas: cancer, malaria and viruses, including HIV, SIV, Zika, SARS, hepatitis and influenza. Additional offerings include biocontainment up to level 3 for both laboratory and laboratory animal research including emerging diseases such as COVID-19.

BIOQ key facts

Ticker symbol

BIOQ

Market tier

Pink

Headquarters

Rockville, MD, United States

Country of incorporation

US

Year of incorporation

1981

Employees

278

Estimated market cap

$49.19M (as of Apr 11, 2025)

Shares outstanding

894,416

Reporting standard

Alternative Reporting Standard

Audit status

Audited

Fiscal year end

5/31

Latest filing

Quarterly Report (Feb 28, 2025)

BIOQUAL, Inc. leadership

• Mark G. Lewis — President, CEO
• Mitchell Franklin — COO
• Charles Kirk, Jr. — CFO
• Hanne Elyard Andersen — CSO

Explore more: Pink stocks · OTC stocks starting with B